Correction: Blood cardioplegia or custodiol for myocardial protection during valvular or aortic surgery: a propensity score adjusted comparison
Related Experiment Video
Updated: Jan 16, 2026

05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
1.2K
Manuel Carnero-Alcazar1, Lourdes Montero-Cruces2,3, Rosa Beltrao-Sial4
1Department of Cardiac Surgery, Hospital Clínico San Carlos, Madrid, Spain. mcarneroalcazar@gmail.com.
Journal of Cardiothoracic Surgery
|October 1, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiopulmonary Resuscitation IV: Pharmacological Management
665
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
665

